Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy

G. Ardissino; S. Salardi; S. Berra; G. Colussi; M. Cugno; M. Zecca; F. Giglio; J. Peccatori; E. Diral; F. Tel; A. Clivio; S. Tedeschi

doi:S1083-8791(17)30460-3 [pii]

Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy

G. Ardissino, S. Salardi, S. Berra, G. Colussi, M. Cugno, M. Zecca, F. Giglio, J. Peccatori, E. Diral, F. Tel, A. Clivio, S. Tedeschi

Research output: Contribution to journal › Article › peer-review

Abstract

Hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is a severe complication whose pathophysiology is unknown. We describe 6 patients in which the disease was associated with complement regulatory gene abnormalities received from their respective donors. It is suggested that mutated and transplanted monocyte-derived cells are responsible for production of abnormal proteins, complement dysregulation, and, ultimately, for the disease. This observation might have important drawbacks as far as HSCT-TMA pathophysiology and treatment are concerned.

Original language	English
Pages (from-to)	1580-1582
Number of pages	3
Journal	Biology of Blood and Marrow Transplantation
Volume	23
Issue number	9
DOIs	https://doi.org/S1083-8791(17)30460-3 [pii]
Publication status	Published - Sep 1 2017

Keywords

Complement
Complement gene mutations
Hematopoietic stem cell transplantation (HSCT)
Hemolytic uremic syndrome
Thrombotic microangiopathy (TMA)

Access to Document

S1083-8791(17)30460-3 [pii]

Fingerprint Dive into the research topics of 'Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy'. Together they form a unique fingerprint.

Cite this

Ardissino, G., Salardi, S., Berra, S., Colussi, G., Cugno, M., Zecca, M., Giglio, F., Peccatori, J., Diral, E., Tel, F., Clivio, A., & Tedeschi, S. (2017). Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation, 23(9), 1580-1582. https://doi.org/S1083-8791(17)30460-3 [pii]

Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy. / Ardissino, G.; Salardi, S.; Berra, S.; Colussi, G.; Cugno, M.; Zecca, M.; Giglio, F.; Peccatori, J.; Diral, E.; Tel, F.; Clivio, A.; Tedeschi, S.

In: Biology of Blood and Marrow Transplantation, Vol. 23, No. 9, 01.09.2017, p. 1580-1582.

Research output: Contribution to journal › Article › peer-review

Ardissino, G, Salardi, S, Berra, S, Colussi, G, Cugno, M , Zecca, M, Giglio, F, Peccatori, J, Diral, E, Tel, F, Clivio, A & Tedeschi, S 2017, 'Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy', Biology of Blood and Marrow Transplantation, vol. 23, no. 9, pp. 1580-1582. https://doi.org/S1083-8791(17)30460-3 [pii]

Ardissino, G. ; Salardi, S. ; Berra, S. ; Colussi, G. ; Cugno, M. ; Zecca, M. ; Giglio, F. ; Peccatori, J. ; Diral, E. ; Tel, F. ; Clivio, A. ; Tedeschi, S. / Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy. In: Biology of Blood and Marrow Transplantation. 2017 ; Vol. 23, No. 9. pp. 1580-1582.

@article{50f0b632047b45ec84975d3b89573dd5,

title = "Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy",

abstract = "Hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is a severe complication whose pathophysiology is unknown. We describe 6 patients in which the disease was associated with complement regulatory gene abnormalities received from their respective donors. It is suggested that mutated and transplanted monocyte-derived cells are responsible for production of abnormal proteins, complement dysregulation, and, ultimately, for the disease. This observation might have important drawbacks as far as HSCT-TMA pathophysiology and treatment are concerned.",

keywords = "Complement, Complement gene mutations, Hematopoietic stem cell transplantation (HSCT), Hemolytic uremic syndrome, Thrombotic microangiopathy (TMA)",

author = "G. Ardissino and S. Salardi and S. Berra and G. Colussi and M. Cugno and M. Zecca and F. Giglio and J. Peccatori and E. Diral and F. Tel and A. Clivio and S. Tedeschi",

note = "LR: 20170820; CI: Copyright (c) 2017; JID: 9600628; OTO: NOTNLM; 2017/03/10 00:00 [received]; 2017/05/09 00:00 [accepted]; 2017/05/20 06:00 [pubmed]; 2017/05/20 06:00 [medline]; 2017/05/20 06:00 [entrez]; ppublish",

year = "2017",

month = sep,

day = "1",

doi = "S1083-8791(17)30460-3 [pii]",

language = "English",

volume = "23",

pages = "1580--1582",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier Inc.",

number = "9",

}

TY - JOUR

T1 - Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy

AU - Ardissino, G.

AU - Salardi, S.

AU - Berra, S.

AU - Colussi, G.

AU - Cugno, M.

AU - Zecca, M.

AU - Giglio, F.

AU - Peccatori, J.

AU - Diral, E.

AU - Tel, F.

AU - Clivio, A.

AU - Tedeschi, S.

N1 - LR: 20170820; CI: Copyright (c) 2017; JID: 9600628; OTO: NOTNLM; 2017/03/10 00:00 [received]; 2017/05/09 00:00 [accepted]; 2017/05/20 06:00 [pubmed]; 2017/05/20 06:00 [medline]; 2017/05/20 06:00 [entrez]; ppublish

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is a severe complication whose pathophysiology is unknown. We describe 6 patients in which the disease was associated with complement regulatory gene abnormalities received from their respective donors. It is suggested that mutated and transplanted monocyte-derived cells are responsible for production of abnormal proteins, complement dysregulation, and, ultimately, for the disease. This observation might have important drawbacks as far as HSCT-TMA pathophysiology and treatment are concerned.

AB - Hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is a severe complication whose pathophysiology is unknown. We describe 6 patients in which the disease was associated with complement regulatory gene abnormalities received from their respective donors. It is suggested that mutated and transplanted monocyte-derived cells are responsible for production of abnormal proteins, complement dysregulation, and, ultimately, for the disease. This observation might have important drawbacks as far as HSCT-TMA pathophysiology and treatment are concerned.

KW - Complement

KW - Complement gene mutations

KW - Hematopoietic stem cell transplantation (HSCT)

KW - Hemolytic uremic syndrome

KW - Thrombotic microangiopathy (TMA)

U2 - S1083-8791(17)30460-3 [pii]

DO - S1083-8791(17)30460-3 [pii]

M3 - Article

VL - 23

SP - 1580

EP - 1582

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 9

ER -